butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of CYP3A4 inducers may well lower sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in sufferers who may have created Actual physical dependence to sufentanil. Disco